Arbutus Biopharma Corp Other Accrued Liabilities, Current
Arbutus Biopharma Corp (ABUS) had Other Accrued Liabilities, Current of $0 as of 2023-12-31, per its 10-K filed 2024-03-05.
Discontinued › Notes › Payables and Accruals
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2024-03-05
- 2023-12-31: Other Accrued Liabilities, Current $0.00.
- 2023-09-30: Other Accrued Liabilities, Current $0.00.
- 2023-06-30: Other Accrued Liabilities, Current $0.00.
- 2023-03-31: Other Accrued Liabilities, Current $6.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-05 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $6.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $6.00K 10-K · filed 2024-03-05 | |
| 2022-09-30 | $6.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$28.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $11.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $31.00K 10-K · filed 2023-03-02 | $5.00K 10-K · filed 2022-03-03 |
| 2021-09-30 | $3.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $2.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $10.00K 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $9.00K 10-K · filed 2022-03-03 | |
| 2020-09-30 | $51.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $6.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $4.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $144.00K 10-K · filed 2021-03-04 | |
| 2019-09-30 | $1.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $2.00K 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $309.00K 10-K · filed 2020-03-05 | |
| 2018-09-30 | $4.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $60.00K 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $322.00K 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $358.00K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $704.00K 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $347.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.72M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $538.00K 10-K · filed 2018-03-16 | |
| 2016-09-30 | $733.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $506.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $47.00K 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $591.00K 10-K · filed 2017-03-22 | |
| 2015-06-30 | $745.00K 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $1.25M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $226.00K 10-K · filed 2016-03-09 | |
| 2014-09-30 | $418.00K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $276.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $510.00K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $795.00K 10-Q · filed 2014-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |